Immunological adjuvants promote activated T cell survival via induction of Bcl-3

Nature Immunology

Volumn 2, Issue 5, 2001, Pages 397-402

  Mitchell, Thomas C ^a,d   Hildeman, David ^a   Kedl, Ross M ^a   Teague, T Kent ^a,e   Schaefer, Brian C ^a   White, Janice ^a   Zhu, Yanan ^a   Kappler, John ^a,b,c   Marrack, Philippa ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d University of Louisville School of Medicine   (United States)

^e UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; LIPOPOLYSACCHARIDE; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL DEATH; CYTOLOGY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; MOUSE; T LYMPHOCYTE; VACCINIA VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL DEATH; FEMALE; GENE EXPRESSION PROFILING; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; VACCINIA VIRUS;

EID: 0035344050     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/87692     Document Type: Article

References (40)

1. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349, 245-248 (1991).
2. Webb, S., Morris, C. & Sprent, J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63, 1249-1256 (1990).
3. McCormack, J. E., Callahan, J. E., Kappler, J. & Marrack, P. C. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150, 3785-3792 (1993).
4. Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
5. Mitchell, T., Kappler, J. & Marrack, P. Bystander virus infection prolongs activated T cell survival. J. Immunol. 162, 4527-4535 (1999).
6. Vella, A. T., McCormack, J. E., Linsley, P. S., Kappler, J. W. & Marrack, P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2, 261-270 (1995).
7. Stywu, H. K., Liblau, R. S. & McDewitt, H. O. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5, 17-30 (1996).
8. Hildeman, D. A. et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744 (1999).
9. Strasser, A., Harris, A. W., Huang, D. C., Kramer, P. H. & Cory, S. Bcl-2 transgene inhibits T cell death and perturbs thymic self- censorship. Cell 67, 889-899 (1991).
10. Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
11. Adams, J. M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326 (1998).
12. Vella, A. T. et al. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158, 4714-4720 (1997).
13. Maxwell, J. R., Campbell, J. D., Kim, C. H. & Vella, A. T. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162, 2024-2034 (1999).
14. Teague, T. K. et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl Acad. Sci. USA 96, 12691-12696 (1999).
15. Barkett, M. & Gilmore, T. D. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18, 6910-6924 (1999).
16. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995).
17. Beg, A. A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784 (1996).
18. Williams, A. F. & Gagnon, J. Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science 216, 696-703 (1982).
19. Fenton, R. G., Marrack, P., Kappler, J. W., Kanagawa, O. & Seidman, J. G. Isotypic exclusion of γδT cell receptors in transgenic mice bearing a rearranged β-chain gene. Science 241, 1089-1092 (1988).
20. lo thymocytes in vivo. Science 250, 1720-1723 (1990).
21. Grumont, R. J. et al. B lymphocytes differentially use the Rel and nuclear factor κBI (NF-κBI) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187, 663-674 (1998).
22. Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Meth. 171, 131-137 (1994).
23. Rebollo, A. et al. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by API and API-like transcription factors. Mol. Cell Biol. 20, 3407-3416 (2000).
24. Aoki, Y. et al. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection. J. Immunol. 153, 3611-3621 (1994).
25. + T cells to cause immunopathology. J. Exp. Med. 187, 763-774 (1998).
26. Rocken, M., Urban, J. F. & Shevach, E. M. Infection breaks T-cell tolerance. Nature 359, 79-82 (1992).
27. White, D. W., Roy, A. & Gilmore, T. D. The v-Rel oncoprotein blocks apoptosis and proteolysis of IκB-α in transformed chicken spleen cells. Oncogene 10, 857-868 (1995).
28. Ohno, H., Takimoto, G. & McKeithan, T. W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991-997 (1990).
29. Kerr, L. D. et al. The proto-oncogene bcl-3 encodes an IκB protein. Genes Dev. 6, 2352-2363 (1992).
30. Nolan, G. P. et al. The bcl-3 proto-oncogene encodes a nuclear I κ B-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell Biol. 13, 3557-3566 (1993).
31. Bours, V. et al. The oncoprotein Bcl-3 directly transactivates through κ B motifs via association with DNA-binding p50B homodimers. Cell 72, 729-739 (1993).
32. Schwarz, E. M., Krimpenfort, P., Berns, A. & Verma, I. M. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11, 187-197 (1997).
33. Franzoso, G. et al. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6, 479-490 (1997).
34. Wulczyn, F. G., Naumann, M. & Scheidereit, C. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358, 597-599 (1992).
35. Chen, F. E. & Ghosh, G. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 18, 6845-6852 (1999).
36. Heath, A. W., Wu, W. W. & Howard, M. C. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24, 1828-1834 (1994).
37. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826 (1998).
38. Bhatia, K. et al. Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. Oncogene 6, 1569-1573 (1991).
39. Naviaux, R. K., Costanzi, E., Haas, M. & Verma, I. M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705 (1996).
40. Norris, P. S., Jepsen, K. & Haas, M. High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo. J. Virol. Meth. 75, 161-167 (1998).